Combining computers and experiments to study the domain composition and function of the PARP protein family

Prediction of protein structure with the artificial intelligence (AI)-powered program AlphaFold2 – hailed by the Science magazine, the biggest scientific breakthrough in 2021 – has rapidly revolutionised protein science. Trained on a large dataset of experimentally determined protein structures, AlphaFold2 can generate a model of a protein’s three-dimensional (tertiary) structure given its amino-acid sequence (primary structure). AlphaFold2 models are highly reliable, thus offering a good basis for understanding the function of proteins whose experimental structure is not available or is not complete.

In the present article, published in the journal Nucleic Acids Research, a collaborative team composed of researchers from Orléans, Oxford, and Cambridge, carefully examined AlphaFold2 models of an important group of proteins called the PARP protein family, which includes 17 proteins in human. These proteins regulate DNA repair and many other cellular pathways by catalysing a protein post-translational modification called protein (ADP-ribosyl)ation. The analysis of AlphaFold2 models allowed annotating all protein domains in this family, several of which have not been annotated before. This analysis served as a starting point for various accompanying experiments which validated some of the insights gained from the predicted models. Featuring an accessible introduction into the new computational approaches, the study can serve as a blueprint for scientists studying other protein families.

Two of the CBM members involved in the study are Marcin J. Suskiewicz and Stéphane Goffinont, both from the group “Protein Post-Translational Modifications: Structure, Function, and Dynamics”. This work is linked to a grant from Ligue contre le Cancer CSIRGO 2023.

References :
Marcin J Suskiewicz and others, Updated protein domain annotation of the PARP protein family sheds new light on biological function, Nucleic Acids Research, 2023;, gkad514,
https://doi.org/10.1093/nar/gkad514

The League Against Cancer supports research carried out at the CBM and the INEM

The committees of the Grand Ouest Cancer League bringing together Brittany, Pays de la Loire, Centre-Val de Loire and Poitou-Charentes pool their resources to support cancer researchers.

On Tuesday 7 February at the CBM, La Ligue contre le cancer officially presented a check for €146,000 to support 6 teams of researchers from the CBM and the INEM (Laboratory of Experimental and Molecular Immunology and Neurogenetics). The projects supported aim to quickly achieve concrete results for the benefit of patients.

The committees of Loiret (represented by its volunteer Administrator, Doctor Jean-Louis Vaur) and Eure-et-Loir (represented by its volunteer Vice-President Mr. Jacques Dautreme) were present. The Loir-et-Cher, Cher and Morbihan committees, which are also funders, could not be present but indicated that they were happy to be able to contribute to the financing of regional research.

Mr. Jean-Marc Schneider from La République du Center came to immortalize this moment by going around the table allowing everyone to present their project as well as the benefits and progress to come.

Marcin Suskiewicz, research fellow at the CBM, obtained an ERC Starting 2022 grant

SUMOylation is a natural reaction that changes the structure of proteins in cells. Thanks to his ERC SUMOwriteNread project, Marcin Suskiewicz of the CBM wants to characterize the mechanism by which it occurs, as well as its effects on the properties of proteins. This reaction remains poorly understood even though it probably plays an essential role in our cells.

Find out more on the CNRS Institute of Chemistry website